# QUantum Genomics Incremental Dosing in Heart Failure - QUID-HF

> **NCT02780180** · PHASE2 · TERMINATED · sponsor: **Quantum Genomics SA** · enrollment: 23 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** QGC001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02780180
- **Lead sponsor:** Quantum Genomics SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-06
- **Primary completion:** 2018-09-12
- **Final completion:** 2018-09-12
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** insufficient recruitment
- **Last updated:** 2018-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02780180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02780180, "QUantum Genomics Incremental Dosing in Heart Failure - QUID-HF". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02780180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*